Evexia Wealth LLC Invests $440,000 in Synopsys, Inc. (NASDAQ:SNPS)

Evexia Wealth LLC acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 837 shares of the semiconductor company's stock, valued at approximately $440,000.

Other large investors have also bought and sold shares of the company. Norges Bank bought a new position in shares of Synopsys during the fourth quarter valued at $583,608,000. Raymond James Financial Inc. bought a new stake in Synopsys during the fourth quarter valued at approximately $199,065,000. Proficio Capital Partners LLC increased its holdings in Synopsys by 71,578.5% during the fourth quarter. Proficio Capital Partners LLC now owns 386,347 shares of the semiconductor company's stock valued at $187,517,000 after buying an additional 385,808 shares during the last quarter. Alecta Tjanstepension Omsesidigt bought a new position in Synopsys in the fourth quarter worth approximately $104,741,000. Finally, American Century Companies Inc. boosted its stake in shares of Synopsys by 38.7% during the 4th quarter. American Century Companies Inc. now owns 571,474 shares of the semiconductor company's stock worth $277,371,000 after acquiring an additional 159,344 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Performance

SNPS stock traded down $1.23 during trading on Monday, reaching $419.98. 468,194 shares of the company traded hands, compared to its average volume of 1,088,974. The business has a 50 day simple moving average of $457.51 and a 200 day simple moving average of $498.01. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The company has a market capitalization of $64.94 billion, a price-to-earnings ratio of 28.92, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23.

Remove Ads

Insider Buying and Selling

In other Synopsys news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. The trade was a 11.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 47,909 shares of company stock worth $22,794,835 in the last ninety days. 0.62% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on SNPS. Piper Sandler lowered their price target on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Morgan Stanley cut their price target on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. Wells Fargo & Company lowered their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Redburn Atlantic assumed coverage on shares of Synopsys in a research report on Monday, January 13th. They set a "buy" rating and a $600.00 target price for the company. Finally, Needham & Company LLC restated a "buy" rating and set a $650.00 price target on shares of Synopsys in a report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $638.58.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.